Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial

The efficacy and safety of polaprezinc combined with triple therapy was compared with triple therapy alone in the eradication of Helicobacter pylori. A randomized, parallel-group, open-label, controlled, prospective multicenter study was conducted in 11 cities in China. Treatment-naive patients with...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Tan, Bei, Luo, Han-Qing, Xu, Hong, Lv, Nong-Hua, Shi, Rui-Hua, Luo, He-Sheng, Li, Jian-Sheng, Ren, Jian-Lin, Zou, Yi-You, Li, Yan-Qing, Ji, Feng, Fang, Jing-Yuan, Qian, Jia-Ming
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5391070/
https://ncbi.nlm.nih.gov/pubmed/28407007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0175625
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires